These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 20655381)

  • 1. Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin.
    Kono S; Yoshida K; Tomosugi N; Terada T; Hamaya Y; Kanaoka S; Miyajima H
    Biochim Biophys Acta; 2010 Nov; 1802(11):968-75. PubMed ID: 20655381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation.
    Wallace DF; McDonald CJ; Ostini L; Iser D; Tuckfield A; Subramaniam VN
    Am J Hematol; 2017 Oct; 92(10):1052-1061. PubMed ID: 28681497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin.
    De Domenico I; Ward DM; di Patti MC; Jeong SY; David S; Musci G; Kaplan J
    EMBO J; 2007 Jun; 26(12):2823-31. PubMed ID: 17541408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.
    Nemeth E; Tuttle MS; Powelson J; Vaughn MB; Donovan A; Ward DM; Ganz T; Kaplan J
    Science; 2004 Dec; 306(5704):2090-3. PubMed ID: 15514116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional iron deficiency in toxic milk mutant mice (tx-J) despite high hepatic ferroportin: a critical role of decreased GPI-ceruloplasmin expression in liver macrophages.
    Jończy A; Lipiński P; Ogórek M; Starzyński RR; Krzysztofik D; Bednarz A; Krzeptowski W; Szudzik M; Haberkiewicz O; Miłoń A; Grzmil P; Lenartowicz M
    Metallomics; 2019 Jun; 11(6):1079-1092. PubMed ID: 31011744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination.
    Qiao B; Sugianto P; Fung E; Del-Castillo-Rueda A; Moran-Jimenez MJ; Ganz T; Nemeth E
    Cell Metab; 2012 Jun; 15(6):918-24. PubMed ID: 22682227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aceruloplasminemia.
    Miyajima H
    Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin and ferroportin: the new players in iron metabolism.
    De Domenico I; Ward DM; Kaplan J
    Semin Liver Dis; 2011 Aug; 31(3):272-9. PubMed ID: 21901657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin targets ferroportin for degradation in hepatocytes.
    Ramey G; Deschemin JC; Durel B; Canonne-Hergaux F; Nicolas G; Vaulont S
    Haematologica; 2010 Mar; 95(3):501-4. PubMed ID: 19773263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.
    Finkenstedt A; Wolf E; Höfner E; Gasser BI; Bösch S; Bakry R; Creus M; Kremser C; Schocke M; Theurl M; Moser P; Schranz M; Bonn G; Poewe W; Vogel W; Janecke AR; Zoller H
    J Hepatol; 2010 Dec; 53(6):1101-7. PubMed ID: 20801540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2.
    De Domenico I; Lo E; Ward DM; Kaplan J
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3800-5. PubMed ID: 19234114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
    Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
    Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aceruloplasminemia.
    Kono S
    Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant mutants of ceruloplasmin impair the copper loading machinery in aceruloplasminemia.
    di Patti MC; Maio N; Rizzo G; De Francesco G; Persichini T; Colasanti M; Polticelli F; Musci G
    J Biol Chem; 2009 Feb; 284(7):4545-54. PubMed ID: 19095659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput screening of small molecules identifies hepcidin antagonists.
    Fung E; Sugianto P; Hsu J; Damoiseaux R; Ganz T; Nemeth E
    Mol Pharmacol; 2013 Mar; 83(3):681-90. PubMed ID: 23292796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron-regulatory gene expression during liver regeneration.
    Mollbrink A; Holmström P; Sjöström M; Hultcrantz R; Eriksson LC; Stål P
    Scand J Gastroenterol; 2012 May; 47(5):591-600. PubMed ID: 22364558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study.
    Nemeth E; Preza GC; Jung CL; Kaplan J; Waring AJ; Ganz T
    Blood; 2006 Jan; 107(1):328-33. PubMed ID: 16141345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin-ferroportin axis in health and disease.
    Ginzburg YZ
    Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune cells and hepatocytes express glycosylphosphatidylinositol-anchored ceruloplasmin at their cell surface.
    Marques L; Auriac A; Willemetz A; Banha J; Silva B; Canonne-Hergaux F; Costa L
    Blood Cells Mol Dis; 2012 Feb; 48(2):110-20. PubMed ID: 22178061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient oxidative folding and site-specific labeling of human hepcidin to study its interaction with receptor ferroportin.
    Luo X; Jiang Q; Song G; Liu YL; Xu ZG; Guo ZY
    FEBS J; 2012 Sep; 279(17):3166-75. PubMed ID: 22776295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.